Development and Validation of a Stability-indicating HPLC Method for Determination of Insulin Detemir and Preservatives in their Injection Products
- سال انتشار: 1401
- محل انتشار: مجله تحقیقات شیمی تجزیه و تجزیه زیستی، دوره: 9، شماره: 1
- کد COI اختصاصی: JR_ANALCH-9-1_007
- زبان مقاله: انگلیسی
- تعداد مشاهده: 123
نویسندگان
Department of Pharmacy, Faculty of Pharmacy, Zarqa University, Zarqa, Jordan
Department of Pharmaceutics and Pharmaceutical Technology, School of Pharmacy, The University of Jordan, Amman, Jordan
Faculty of Pharmacy, Philadelphia University, ۱۹۳۹۲ Amman, Jordan
Department of Pharmaceutical Sciences, School of Pharmacy, The University of Jordan, Amman, Jordan
چکیده
Insulin detemir (ID) is a long-acting form of insulin that is characterized by the covalent attachment of a lipophilic tail of myristate, and commercially available as Levemir®. No satisfactory simple isocratic stability-indicating HPLC method has been reported for its quality control. A novel simple and isocratic reversed-phase HPLC method was developed and validated for the simultaneous determination of ID along with its dosage form additives in the available commercial preparations. The method employed C۴ column (۵μm, ۲۵۰ × ۴.۶ mm), a mobile phase consisting of ۵۰ mM phosphate buffer pH ۲.۷, acetonitrile, triethylamine (۶۲:۳۷:۱) and ۰.۰۲ g/ml sodium sulfate, that was delivered isocraticaly at a flow rate of ۱.۵ ml/min, and detection performed at ۲۱۴nm. The method was properly validated and was shown linear over the range ۸۰–۱۲۰% of the assay concentration for ID, phenol, and m-cresol. The method was also selective, specific, precise, and accurate. Furthermore, the validated method was applied to separate the major degradation products in those preparations. Forced degradation studies in different pH values, which are the first to be reported for ID, showed that the degradation products were baseline separated from ID itself and/or other formulation additives. Thus, the method has been demonstrated to be a stability-indicating assay.کلیدواژه ها
Detemir, insulin, Stability-indicating, HPLCاطلاعات بیشتر در مورد COI
COI مخفف عبارت CIVILICA Object Identifier به معنی شناسه سیویلیکا برای اسناد است. COI کدی است که مطابق محل انتشار، به مقالات کنفرانسها و ژورنالهای داخل کشور به هنگام نمایه سازی بر روی پایگاه استنادی سیویلیکا اختصاص می یابد.
کد COI به مفهوم کد ملی اسناد نمایه شده در سیویلیکا است و کدی یکتا و ثابت است و به همین دلیل همواره قابلیت استناد و پیگیری دارد.